Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases
Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases
Date
2017-04
Authors
Brady, Scott T.
Morfini, Gerardo A.
Morfini, Gerardo A.
Linked Authors
Alternative Title
Citable URI
As Published
Date Created
Location
DOI
Related Materials
Replaces
Replaced By
Keywords
Abstract
Neurons affected in a wide variety of unrelated adult-onset neurodegenerative diseases (AONDs) typically
exhibit a “dying back” pattern of degeneration, which is characterized by early deficits in synaptic function and
neuritic pathology long before neuronal cell death. Consistent with this observation, multiple unrelated AONDs
including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and several motor neuron diseases
feature early alterations in kinase-based signaling pathways associated with deficits in axonal transport (AT), a
complex cellular process involving multiple intracellular trafficking events powered by microtubule-based motor
proteins. These pathogenic events have important therapeutic implications, suggesting that a focus on
preservation of neuronal connections may be more effective to treat AONDs than addressing neuronal cell
death. While the molecular mechanisms underlying AT abnormalities in AONDs are still being analyzed,
evidence has accumulated linking those to a well-established pathological hallmark of multiple AONDs: altered
patterns of neuronal protein phosphorylation. Here, we present a short overview on the biochemical
heterogeneity of major motor proteins for AT, their regulation by protein kinases, and evidence revealing cell
type-specific AT specializations. When considered together, these findings may help explain how independent
pathogenic pathways can affect AT differentially in the context of each AOND.
Description
© The Author(s), 2017. This is the author's version of the work and is distributed under the terms of the Creative Commons Attribution License. The definitive version was published in Neurobiology of Disease 105 (2017): 273-282, doi:10.1016/j.nbd.2017.04.010.